Logo

EDBL

Edible Garden AG Incorporated

EDBL

Edible Garden AG Incorporated NASDAQ
$1.23 2.50% (+0.03)

Market Cap $3.60 M
52w High $13.50
52w Low $1.04
Dividend Yield 0%
P/E 0.03
Volume 12.04K
Outstanding Shares 2.92M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $2.817M $3.831M $-4.045M -143.592% $-1.38 $-2.544M
Q2-2025 $3.146M $4.227M $-4.043M -128.512% $-6.58 $-3.219M
Q1-2025 $2.718M $3.014M $-3.324M -122.296% $-2.47 $-2.583M
Q4-2024 $3.872M $2.764M $-3.079M -79.52% $-2.2 $-3.083M
Q3-2024 $2.584M $2.189M $-2.063M -79.837% $-0.65 $-1.409M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $828K $20.132M $7.209M $12.923M
Q2-2025 $2.821M $21.814M $5.222M $16.592M
Q1-2025 $409K $8.535M $6.617M $1.918M
Q4-2024 $3.53M $11.915M $7.821M $4.094M
Q3-2024 $2.214M $8.863M $5.604M $3.259M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $-4.045M $-2.378M $-409K $794K $-1.993M $-2.787M
Q2-2025 $-4.043M $-3.432M $-54K $5.898M $2.412M $-3.486M
Q1-2025 $-3.324M $-3.332M $-68K $279K $-3.121M $-3.411M
Q4-2024 $-3.079M $-1.755M $-126K $3.197M $1.316M $-1.881M
Q3-2024 $-2.063M $-1.112M $-10K $1.148M $26K $-1.122M

Revenue by Products

Product Q3-2024Q4-2024Q1-2025Q2-2025
Vitamins and Supplements
Vitamins and Supplements
$0 $0 $0 $0

Five-Year Company Overview

Income Statement

Income Statement The company looks like it is still in “build” mode rather than “harvest” mode. Revenue appears very small and fairly flat, while operating costs continue to exceed what the business brings in. That shows up as recurring operating and net losses year after year, suggesting the core business is not yet scaled or efficient enough to cover its own cost base.


Balance Sheet

Balance Sheet The balance sheet looks thin and fragile. The asset base is very small, reported cash is minimal, and equity has hovered around breakeven or even dipped negative in the past, with only modest amounts of debt. This combination signals limited financial cushion and a business that does not have much room to absorb setbacks without fresh capital or a rapid improvement in profitability.


Cash Flow

Cash Flow Cash flow from day‑to‑day operations has been consistently negative, and free cash flow has also been negative, with little visible investment in long‑term assets. In plain terms, the business has been consuming cash rather than generating it. That means continued reliance on external funding or new capital raises unless the company can turn its operations cash‑positive.


Competitive Edge

Competitive Edge On the strategic side, the company has some clear differentiators: a sustainability‑driven brand, patented greenhouse and in‑store technologies, and relationships with large retailers. Its “seed‑to‑store” control and focus on zero‑waste, traceability, and eco‑friendly packaging fit well with current consumer trends. However, it operates in very competitive, low‑margin categories and remains much smaller than big food and produce players, which limits its bargaining power and makes execution on its strategy especially important.


Innovation and R&D

Innovation and R&D Innovation is a relative bright spot. The firm is investing in proprietary software for traceability, shelf‑life‑extending packaging, self‑watering displays, and new growing technologies like nanobubbles, along with moves into aquaculture and nutraceuticals. It is also pushing into higher‑margin, shelf‑stable consumer products and fermented foods, supported by new facilities and potential acquisitions. The big uncertainty is how quickly and reliably these projects can be commercialized given the company’s limited financial resources.


Summary

Overall, Edible Garden AG combines an appealing sustainability story and interesting ag‑tech innovations with a very constrained financial profile. The business has not yet demonstrated consistent scale or profitability, cash generation is weak, and several reverse stock splits point to ongoing capital market and listing pressure. At the same time, the company is trying to pivot into higher‑margin products and leverage its patents, data systems, and retailer relationships. The key questions ahead are whether it can grow revenue meaningfully, lift margins, and fund its innovation pipeline without overstretching its already thin balance sheet.